Our products in the US

We provide non-injectable and injectable generic medicines in the United States.

High-quality medicines to treat a range of conditions

High-quality medicines to treat a range of conditions

In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.

Quick Links

Injectables Catalog

Injectables Catalog

Supplier Code of Conduct

Supplier Code of Conduct

Mitigare®

Mitigare®

Return of Goods Policy

Return of Goods Policy

Non-injectables Catalog

Non-injectables Catalog

Related news

Hikma launches Bupivacaine HCl Injection, USP
20 December 2021
Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia® and Xgeva®
9 December 2021
Hikma launches Micafungin for Injection
12 October 2021